Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas

Abroad (travel likely)RecruitingPHASE1

Conditions

Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Rosy Njonkou Tchoquessi, Baltimore, Maryland, United States
Contact: Study coordinator (Rosy Njonkou Tchoquessi) · rnjonkou@som.umaryland.edu · 4107066445

Study leads

Dirk Mayer, Dr. rer. nat
Principal Investigator
University of Maryland, Baltimore

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Astrocytoma · Glioma · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

F-Tryptophan PET/CT in Human Cancers

Intracranial Glioma · Metastatic Brain Tumor · Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Detroit, United States

Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations

Gliomas Harboring IDH1 and/or IDH2 Mutations

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

BC008-1A Injection for Recurrent CNS WHO G4 Glioma

Glioma · Glioma Tumor Recurrence · Glioma, Recurrent High Grade

Abroad (travel likely)RecruitingPHASE1

Beijing, China